Multicenter prospective study of erlotinib in advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations

被引：0
|
作者：
Cardenal, Felipe [2 ]
Moran, Teresa [1 ]
Queralt, Cristina [1 ]
Porta, Ruth [3 ]
Camps, Carlos [4 ]
Majem, Margarita [5 ]
Lopez-Vivanco, Guillermo [6 ]
Isla, Dolores [7 ]
Provencio, Mariano [8 ]
Sanchez, Jose Javier [9 ]
Taron, Miquel [1 ]
Rosell, Rafael [1 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain
[2] Hosp Duran & Reynals, Catalan Inst Oncol, Bellvitge, Spain
[3] Hosp Trueta, Girona, Spain
[4] Hosp Gen Valencia, Valencia, Spain
[5] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[6] Hosp Cruces, Cruces Baracaldo, Spain
[7] Hosp Lozano Blesa, Zaragoza, Spain
[8] Hosp Puerta de Hierro, Madrid, Spain
[9] Autonomous Univ Madrid, E-28049 Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S324 / S325
页数：2
相关论文
共 50 条
  • [31] The quantification of epidermal growth factor receptor (EGFR) in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients
    Camps, C.
    Sirera, R.
    Munoz-Navarro, M.
    Lopez-Vivanco, G.
    Alonso, G.
    Provencio, M.
    Gonzalez-Larriba, J.
    de las Penas, R.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Brain Metastasis in Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Bhatt, Vijaya R.
    Kedia, Shiksha
    Kessinger, Anne
    Ganti, Apar K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3162 - 3164
  • [33] Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
    Lee, Kyung-Hun
    Han, Sae-Won
    Hwang, Pil Gyu
    Oh, Do-Youn
    Kim, Dong-Wan
    Chung, Doo Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Heo, Dae Seog
    Bang, Yung-Jue
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (06) : 344 - 350
  • [34] Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression
    Reguart, Noemi
    Rosell, Rafael
    Cardenal, Felipe
    Cardona, Andres F.
    Isla, Dolores
    Palmero, Ramon
    Moran, Teresa
    Rolfo, Christian
    Pallares, M. Cinta
    Insa, Amelia
    Carcereny, Enric
    Majem, Margarita
    De Castro, Javier
    Queralt, Cristina
    Molina, Miguel A.
    Taron, Miquel
    LUNG CANCER, 2014, 84 (02) : 161 - 167
  • [35] Response to first-line chemotherapy and sensitivity to epidermal growth factor receptor (EGFR) inhibitors in advanced non-small-cell lung cancer (NSCLC) patients
    Betti, Maura
    Toschi, L.
    Metro, G.
    Bartolini, Stefania
    Magrini, E.
    de Angelis, Verena
    Chiari, Rita
    Ferraldeschi, Massimiliano
    Cappuzzo, Federico
    Crino, Lucio
    ANNALS OF ONCOLOGY, 2006, 17 : 235 - 235
  • [36] Epidermal growth factor receptor (EGFR) inhibition on non-small-cell lung cancer treatment
    Kowalski, Dariusz M.
    Krzakowski, Maciej
    Janowicz-Zebrowska, Anna
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (04): : 177 - 182
  • [37] Clinical characteristics and natural history of patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations treated with erlotinib or gefitinib.
    Riely, GJ
    Miller, VA
    Pao, W
    Zakowski, M
    Ladanyi, M
    Heelan, RT
    Kris, MG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 641S - 641S
  • [38] DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR IN SERUM AND TISSUE OF PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC)
    Pistola, L.
    Ludovini, V.
    Gregorc, V.
    Bellezza, G.
    Darwish, S.
    Rulli, E.
    Compagnoni, A.
    Sidoni, A.
    Scheibel, M.
    Myhailova, Z.
    Ragusa, M.
    Di Carlo, L.
    Tofanetti, F. R.
    Bellet, M. M.
    Ferraldeschi, M.
    Daddi, G.
    Tonato, M.
    ANNALS OF ONCOLOGY, 2004, 15 : 37 - 37
  • [39] Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China
    Zhou, Yongchun
    Yang, Yanlong
    Yang, Chenggang
    Chen, Yunlan
    Yang, Changshao
    Du, Yaxi
    Zhao, Guangqiang
    Guo, Yinjin
    Ye, Lianhua
    Huang, Yunchao
    ONCOTARGET, 2017, 8 (09) : 15023 - 15033
  • [40] Prevalence of epidermal growth factor receptor (EGFR) gene mutations in non small cell lung cancer (NSCLC) in Bulgarian population
    Popovska, S.
    Chilingirova, N.
    Dineva, T.
    Kamburova, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S128 - S129
12345